Karjosukarso et al. investigate antisense oligonucleotides targeting aberrant splicing caused by a recurrent ABCA4 variant in Stargardt disease. A candidate therapeutic molecule that shows a favorable efficacy and safety profile was selected for further investigation.
- Dyah W. Karjosukarso
- Femke Bukkems
- Rob W. J. Collin